# Xiaoping Su

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/xiaoping-su/

## Facts

| Field | Value |
| --- | --- |
| Citations | 45,453 |
| Field | Renal cell carcinoma treatment |
| h-index | 80 |
| i10-index | 173 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5072226386 |
| ORCID iD | https://orcid.org/0000-0003-1824-943X |
| Works | 732 |

## Researcher papers

- [Radial glia cells are candidate stem cells of ependymoma](https://scholariq.org/papers/radial-glia-cells-are-candidate-stem-cells-of-ependymoma/)
- [Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6](https://scholariq.org/papers/tet2-is-required-to-resolve-inflammation-by-recruiting-hdac2-to-specifically/)

## Researcher topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.